The co-occurrence of Alzheimer’s disease in the ageing Huntington’s disease brains was controlled by selecting Huntington’s disease cases that were free of any amyloid-β and tau pathology according to standard procedures (Braak and Braak, 1991). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.